Reformulating Drug Products That Contain Carbomers Manufactured With Benzene
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
December 28, 2023
December 27, 2023
eca61c4a-9786-4068-b4e8-00d8444874c6
Related Documents
Temporary Policies for Compounding Certain Starter Parenteral Nutrition Drug Products for Neonates: Guidance for Industry
Guidance DocumentSeptember 8, 2026Center for Drug Evaluation and Research
Recommended Acceptable Intake Limits for Nitrosamine Drug Substance-Related Impurities
Guidance DocumentAugust 7, 2023Center for Drug Evaluation and Research
Development of Monoclonal Antibody Products Targeting SARS-CoV-2 for Emergency Use Authorization
Guidance DocumentDecember 21, 2023Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.